entg-20230930false2023Q3ENTEGRIS INC0001101302--12-3100011013022023-01-012023-09-3000011013022023-10-30xbrli:shares00011013022023-09-30iso4217:USD00011013022022-12-31iso4217:USDxbrli:shares00011013022023-07-022023-09-3000011013022022-07-032022-10-0100011013022022-01-012022-10-0100011013022022-01-012022-12-310001101302us-gaap:CommonStockMember2021-12-310001101302us-gaap:TreasuryStockCommonMember2021-12-310001101302us-gaap:AdditionalPaidInCapitalMember2021-12-310001101302us-gaap:RetainedEarningsMember2021-12-310001101302us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-3100011013022021-12-310001101302us-gaap:CommonStockMember2022-01-012022-04-020001101302us-gaap:TreasuryStockCommonMember2022-01-012022-04-020001101302us-gaap:AdditionalPaidInCapitalMember2022-01-012022-04-020001101302us-gaap:RetainedEarningsMember2022-01-012022-04-020001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-04-020001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-04-020001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-04-0200011013022022-01-012022-04-0200011013022022-01-012022-07-020001101302us-gaap:CommonStockMember2022-04-020001101302us-gaap:TreasuryStockCommonMember2022-04-020001101302us-gaap:AdditionalPaidInCapitalMember2022-04-020001101302us-gaap:RetainedEarningsMember2022-04-020001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-04-020001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-020001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-0200011013022022-04-020001101302us-gaap:CommonStockMember2022-04-032022-07-020001101302us-gaap:TreasuryStockCommonMember2022-04-032022-07-020001101302us-gaap:AdditionalPaidInCapitalMember2022-04-032022-07-020001101302us-gaap:RetainedEarningsMember2022-04-032022-07-020001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-04-032022-07-020001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-032022-07-020001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-032022-07-0200011013022022-04-032022-07-020001101302us-gaap:CommonStockMember2022-07-020001101302us-gaap:TreasuryStockCommonMember2022-07-020001101302us-gaap:AdditionalPaidInCapitalMember2022-07-020001101302us-gaap:RetainedEarningsMember2022-07-020001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-07-020001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-020001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-0200011013022022-07-020001101302us-gaap:CommonStockMember2022-07-032022-10-010001101302us-gaap:TreasuryStockCommonMember2022-07-032022-10-010001101302us-gaap:AdditionalPaidInCapitalMember2022-07-032022-10-010001101302us-gaap:RetainedEarningsMember2022-07-032022-10-010001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-07-032022-10-010001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-032022-10-010001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-032022-10-0100011013022022-10-022022-12-310001101302us-gaap:CommonStockMember2022-10-010001101302us-gaap:TreasuryStockCommonMember2022-10-010001101302us-gaap:AdditionalPaidInCapitalMember2022-10-010001101302us-gaap:RetainedEarningsMember2022-10-010001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-10-010001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-10-010001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-10-0100011013022022-10-010001101302us-gaap:CommonStockMember2022-12-310001101302us-gaap:TreasuryStockCommonMember2022-12-310001101302us-gaap:AdditionalPaidInCapitalMember2022-12-310001101302us-gaap:RetainedEarningsMember2022-12-310001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001101302us-gaap:CommonStockMember2023-01-012023-04-010001101302us-gaap:TreasuryStockCommonMember2023-01-012023-04-010001101302us-gaap:AdditionalPaidInCapitalMember2023-01-012023-04-010001101302us-gaap:RetainedEarningsMember2023-01-012023-04-010001101302us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-04-010001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-04-010001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-04-0100011013022023-01-012023-04-010001101302us-gaap:CommonStockMember2023-04-010001101302us-gaap:TreasuryStockCommonMember2023-04-010001101302us-gaap:AdditionalPaidInCapitalMember2023-04-010001101302us-gaap:RetainedEarningsMember2023-04-010001101302us-gaap:AccumulatedTranslationAdjustmentMember2023-04-010001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-04-010001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-04-0100011013022023-04-010001101302us-gaap:CommonStockMember2023-04-022023-07-010001101302us-gaap:TreasuryStockCommonMember2023-04-022023-07-010001101302us-gaap:AdditionalPaidInCapitalMember2023-04-022023-07-010001101302us-gaap:RetainedEarningsMember2023-04-022023-07-010001101302us-gaap:AccumulatedTranslationAdjustmentMember2023-04-022023-07-010001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-04-022023-07-010001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-04-022023-07-0100011013022023-04-022023-07-010001101302us-gaap:CommonStockMember2023-01-012023-09-300001101302us-gaap:TreasuryStockCommonMember2023-01-012023-09-300001101302us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001101302us-gaap:RetainedEarningsMember2023-01-012023-09-300001101302us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-09-300001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-09-300001101302us-gaap:CommonStockMember2023-07-010001101302us-gaap:TreasuryStockCommonMember2023-07-010001101302us-gaap:AdditionalPaidInCapitalMember2023-07-010001101302us-gaap:RetainedEarningsMember2023-07-010001101302us-gaap:AccumulatedTranslationAdjustmentMember2023-07-010001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-010001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-0100011013022023-07-010001101302us-gaap:CommonStockMember2023-07-022023-09-300001101302us-gaap:TreasuryStockCommonMember2023-07-022023-09-300001101302us-gaap:AdditionalPaidInCapitalMember2023-07-022023-09-300001101302us-gaap:RetainedEarningsMember2023-07-022023-09-300001101302us-gaap:AccumulatedTranslationAdjustmentMember2023-07-022023-09-300001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-022023-09-300001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-022023-09-300001101302us-gaap:CommonStockMember2023-09-300001101302us-gaap:TreasuryStockCommonMember2023-09-300001101302us-gaap:AdditionalPaidInCapitalMember2023-09-300001101302us-gaap:RetainedEarningsMember2023-09-300001101302us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-09-3000011013022022-07-062022-07-060001101302entg:CMCMaterialsMember2023-01-012023-09-300001101302entg:CMCMaterialsMember2022-07-062022-07-060001101302entg:CMCMaterialsMember2022-07-060001101302us-gaap:SecuredDebtMember2022-07-060001101302entg:SeniorSecuredNotesDue2029Member2022-07-060001101302entg:SeniorUnsecuredNotesDue2030Member2022-07-060001101302us-gaap:BridgeLoanMember2022-07-0600011013022022-07-060001101302entg:CMCMaterialsMemberus-gaap:DevelopedTechnologyRightsMember2022-07-060001101302entg:CMCMaterialsMemberus-gaap:DevelopedTechnologyRightsMember2022-07-062022-07-060001101302entg:CMCMaterialsMemberus-gaap:TrademarksAndTradeNamesMember2022-07-060001101302entg:CMCMaterialsMemberus-gaap:TrademarksAndTradeNamesMember2022-07-062022-07-060001101302entg:CMCMaterialsMemberus-gaap:CustomerRelationshipsMember2022-07-060001101302entg:CMCMaterialsMemberus-gaap:CustomerRelationshipsMember2022-07-062022-07-060001101302entg:CMCMaterialsMemberus-gaap:InProcessResearchAndDevelopmentMember2022-07-060001101302entg:CMCMaterialsMemberus-gaap:InProcessResearchAndDevelopmentMember2022-07-062022-07-060001101302us-gaap:OtherIntangibleAssetsMemberentg:CMCMaterialsMember2022-07-060001101302us-gaap:OtherIntangibleAssetsMemberentg:CMCMaterialsMember2022-07-062022-07-0600011013022023-02-102023-02-100001101302entg:PIMMember2023-02-102023-02-100001101302entg:PIMMember2023-01-012023-09-300001101302entg:PIMMember2023-09-300001101302entg:PIMMember2023-07-022023-09-300001101302entg:ECMember2023-07-022023-09-300001101302entg:ECMember2023-01-012023-09-300001101302entg:ECMember2023-09-300001101302us-gaap:SubsequentEventMember2023-10-022023-10-020001101302entg:QEDMember2023-01-012023-09-300001101302entg:QEDMember2023-03-012023-03-0100011013022023-03-012023-03-010001101302entg:QEDMember2023-03-010001101302entg:QEDMember2023-09-300001101302entg:MaterialsSciencesMember2022-12-310001101302entg:MicrocontaminationControlMember2022-12-310001101302entg:AdvancedMaterialsHandlingAMHMember2022-12-310001101302entg:MaterialsSciencesMember2023-09-300001101302entg:MicrocontaminationControlMember2023-09-300001101302entg:AdvancedMaterialsHandlingAMHMember2023-09-300001101302entg:MaterialsSciencesMember2023-01-012023-09-300001101302entg:MicrocontaminationControlMember2023-01-012023-09-300001101302entg:AdvancedMaterialsHandlingAMHMember2023-01-012023-09-300001101302us-gaap:DevelopedTechnologyRightsMember2023-09-300001101302us-gaap:TrademarksAndTradeNamesMember2023-09-300001101302us-gaap:CustomerRelationshipsMember2023-09-300001101302us-gaap:InProcessResearchAndDevelopmentMember2023-09-300001101302us-gaap:OtherIntangibleAssetsMember2023-09-300001101302us-gaap:DevelopedTechnologyRightsMember2022-12-310001101302us-gaap:TrademarksAndTradeNamesMember2022-12-310001101302us-gaap:CustomerRelationshipsMember2022-12-310001101302us-gaap:InProcessResearchAndDevelopmentMember2022-12-310001101302us-gaap:OtherIntangibleAssetsMember2022-12-310001101302entg:SecuredDebtDue2029Member2023-09-300001101302entg:SecuredDebtDue2029Member2022-12-310001101302entg:SeniorSecuredNotesDue2029Member2023-09-300001101302entg:SeniorSecuredNotesDue2029Member2022-12-310001101302entg:SeniorUnsecuredNotesDue2030Member2023-09-300001101302entg:SeniorUnsecuredNotesDue2030Member2022-12-310001101302entg:SeniorUnsecuredNotesDue2029Member2023-09-300001101302entg:SeniorUnsecuredNotesDue2029Member2022-12-310001101302entg:SeniorUnsecuredNotesDue2028Member2023-09-300001101302entg:SeniorUnsecuredNotesDue2028Member2022-12-310001101302us-gaap:BridgeLoanMember2023-09-300001101302us-gaap:BridgeLoanMember2022-12-310001101302us-gaap:LongTermDebtMember2023-09-300001101302us-gaap:LongTermDebtMember2022-12-310001101302us-gaap:SecuredDebtMember2023-07-01xbrli:pure0001101302us-gaap:SecuredDebtMember2023-04-022023-07-010001101302us-gaap:SecuredDebtMember2023-09-300001101302us-gaap:SecuredDebtMember2023-07-022023-09-300001101302entg:SecuredDebtDue2029Member2023-07-022023-09-300001101302entg:SecuredDebtDue2029Member2023-01-012023-09-3000011013022023-04-202023-04-200001101302us-gaap:FairValueInputsLevel1Member2023-09-300001101302us-gaap:FairValueInputsLevel1Member2022-12-310001101302us-gaap:FairValueInputsLevel2Member2023-09-300001101302us-gaap:FairValueInputsLevel2Member2022-12-310001101302us-gaap:FairValueInputsLevel3Member2023-09-300001101302us-gaap:FairValueInputsLevel3Member2022-12-310001101302us-gaap:FairValueInputsLevel12And3Member2023-09-300001101302us-gaap:FairValueInputsLevel12And3Member2022-12-310001101302us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2023-09-300001101302us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2022-12-310001101302us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2023-09-300001101302us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2023-09-300001101302us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2022-12-310001101302us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel12And3Member2023-09-300001101302us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel12And3Member2022-12-310001101302us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2022-12-310001101302us-gaap:FairValueInputsLevel12And3Memberus-gaap:ForeignExchangeContractMember2022-12-310001101302us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:LongMember2023-09-300001101302us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:LongMember2022-12-310001101302us-gaap:ShortMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-09-300001101302us-gaap:ShortMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-12-310001101302us-gaap:InterestRateSwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001101302us-gaap:InterestRateSwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2023-09-300001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2022-12-310001101302us-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-09-300001101302us-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-12-310001101302us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMember2023-09-300001101302us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMember2022-12-310001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-022023-09-300001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-032022-10-010001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-10-010001101302us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-07-022023-09-300001101302us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-07-032022-10-010001101302us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-01-012023-09-300001101302us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-01-012022-10-010001101302entg:MaterialsSciencesMember2023-07-022023-09-300001101302entg:MaterialsSciencesMember2022-07-032022-10-010001101302entg:MaterialsSciencesMember2022-01-012022-10-010001101302entg:MicrocontaminationControlMember2023-07-022023-09-300001101302entg:MicrocontaminationControlMember2022-07-032022-10-010001101302entg:MicrocontaminationControlMember2022-01-012022-10-010001101302entg:AdvancedMaterialsHandlingAMHMember2023-07-022023-09-300001101302entg:AdvancedMaterialsHandlingAMHMember2022-07-032022-10-010001101302entg:AdvancedMaterialsHandlingAMHMember2022-01-012022-10-010001101302entg:IntersegmentSalesEliminationMember2023-07-022023-09-300001101302entg:IntersegmentSalesEliminationMember2022-07-032022-10-010001101302entg:IntersegmentSalesEliminationMember2023-01-012023-09-300001101302entg:IntersegmentSalesEliminationMember2022-01-012022-10-010001101302entg:MaterialsSciencesMembercountry:US2023-07-022023-09-300001101302entg:MicrocontaminationControlMembercountry:US2023-07-022023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembercountry:US2023-07-022023-09-300001101302entg:IntersegmentSalesEliminationMembercountry:US2023-07-022023-09-300001101302country:US2023-07-022023-09-300001101302country:TWentg:MaterialsSciencesMember2023-07-022023-09-300001101302country:TWentg:MicrocontaminationControlMember2023-07-022023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembercountry:TW2023-07-022023-09-300001101302country:TWentg:IntersegmentSalesEliminationMember2023-07-022023-09-300001101302country:TW2023-07-022023-09-300001101302entg:MaterialsSciencesMembercountry:CN2023-07-022023-09-300001101302entg:MicrocontaminationControlMembercountry:CN2023-07-022023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembercountry:CN2023-07-022023-09-300001101302entg:IntersegmentSalesEliminationMembercountry:CN2023-07-022023-09-300001101302country:CN2023-07-022023-09-300001101302entg:MaterialsSciencesMembercountry:KR2023-07-022023-09-300001101302entg:MicrocontaminationControlMembercountry:KR2023-07-022023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembercountry:KR2023-07-022023-09-300001101302entg:IntersegmentSalesEliminationMembercountry:KR2023-07-022023-09-300001101302country:KR2023-07-022023-09-300001101302country:JPentg:MaterialsSciencesMember2023-07-022023-09-300001101302country:JPentg:MicrocontaminationControlMember2023-07-022023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembercountry:JP2023-07-022023-09-300001101302country:JPentg:IntersegmentSalesEliminationMember2023-07-022023-09-300001101302country:JP2023-07-022023-09-300001101302entg:MaterialsSciencesMembersrt:EuropeMember2023-07-022023-09-300001101302entg:MicrocontaminationControlMembersrt:EuropeMember2023-07-022023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembersrt:EuropeMember2023-07-022023-09-300001101302entg:IntersegmentSalesEliminationMembersrt:EuropeMember2023-07-022023-09-300001101302srt:EuropeMember2023-07-022023-09-300001101302entg:SoutheastAsiaMemberentg:MaterialsSciencesMember2023-07-022023-09-300001101302entg:SoutheastAsiaMemberentg:MicrocontaminationControlMember2023-07-022023-09-300001101302entg:SoutheastAsiaMemberentg:AdvancedMaterialsHandlingAMHMember2023-07-022023-09-300001101302entg:SoutheastAsiaMemberentg:IntersegmentSalesEliminationMember2023-07-022023-09-300001101302entg:SoutheastAsiaMember2023-07-022023-09-300001101302entg:MaterialsSciencesMembercountry:US2022-07-032022-10-010001101302entg:MicrocontaminationControlMembercountry:US2022-07-032022-10-010001101302entg:AdvancedMaterialsHandlingAMHMembercountry:US2022-07-032022-10-010001101302entg:IntersegmentSalesEliminationMembercountry:US2022-07-032022-10-010001101302country:US2022-07-032022-10-010001101302country:TWentg:MaterialsSciencesMember2022-07-032022-10-010001101302country:TWentg:MicrocontaminationControlMember2022-07-032022-10-010001101302entg:AdvancedMaterialsHandlingAMHMembercountry:TW2022-07-032022-10-010001101302country:TWentg:IntersegmentSalesEliminationMember2022-07-032022-10-010001101302country:TW2022-07-032022-10-010001101302entg:MaterialsSciencesMembercountry:CN2022-07-032022-10-010001101302entg:MicrocontaminationControlMembercountry:CN2022-07-032022-10-010001101302entg:AdvancedMaterialsHandlingAMHMembercountry:CN2022-07-032022-10-010001101302entg:IntersegmentSalesEliminationMembercountry:CN2022-07-032022-10-010001101302country:CN2022-07-032022-10-010001101302entg:MaterialsSciencesMembercountry:KR2022-07-032022-10-010001101302entg:MicrocontaminationControlMembercountry:KR2022-07-032022-10-010001101302entg:AdvancedMaterialsHandlingAMHMembercountry:KR2022-07-032022-10-010001101302entg:IntersegmentSalesEliminationMembercountry:KR2022-07-032022-10-010001101302country:KR2022-07-032022-10-010001101302country:JPentg:MaterialsSciencesMember2022-07-032022-10-010001101302country:JPentg:MicrocontaminationControlMember2022-07-032022-10-010001101302entg:AdvancedMaterialsHandlingAMHMembercountry:JP2022-07-032022-10-010001101302country:JPentg:IntersegmentSalesEliminationMember2022-07-032022-10-010001101302country:JP2022-07-032022-10-010001101302entg:MaterialsSciencesMembersrt:EuropeMember2022-07-032022-10-010001101302entg:MicrocontaminationControlMembersrt:EuropeMember2022-07-032022-10-010001101302entg:AdvancedMaterialsHandlingAMHMembersrt:EuropeMember2022-07-032022-10-010001101302entg:IntersegmentSalesEliminationMembersrt:EuropeMember2022-07-032022-10-010001101302srt:EuropeMember2022-07-032022-10-010001101302entg:SoutheastAsiaMemberentg:MaterialsSciencesMember2022-07-032022-10-010001101302entg:SoutheastAsiaMemberentg:MicrocontaminationControlMember2022-07-032022-10-010001101302entg:SoutheastAsiaMemberentg:AdvancedMaterialsHandlingAMHMember2022-07-032022-10-010001101302entg:SoutheastAsiaMemberentg:IntersegmentSalesEliminationMember2022-07-032022-10-010001101302entg:SoutheastAsiaMember2022-07-032022-10-010001101302entg:MaterialsSciencesMembercountry:US2023-01-012023-09-300001101302entg:MicrocontaminationControlMembercountry:US2023-01-012023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembercountry:US2023-01-012023-09-300001101302entg:IntersegmentSalesEliminationMembercountry:US2023-01-012023-09-300001101302country:US2023-01-012023-09-300001101302country:TWentg:MaterialsSciencesMember2023-01-012023-09-300001101302country:TWentg:MicrocontaminationControlMember2023-01-012023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembercountry:TW2023-01-012023-09-300001101302country:TW2023-01-012023-09-300001101302entg:MaterialsSciencesMembercountry:CN2023-01-012023-09-300001101302entg:MicrocontaminationControlMembercountry:CN2023-01-012023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembercountry:CN2023-01-012023-09-300001101302country:CN2023-01-012023-09-300001101302entg:MaterialsSciencesMembercountry:KR2023-01-012023-09-300001101302entg:MicrocontaminationControlMembercountry:KR2023-01-012023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembercountry:KR2023-01-012023-09-300001101302country:KR2023-01-012023-09-300001101302country:JPentg:MaterialsSciencesMember2023-01-012023-09-300001101302country:JPentg:MicrocontaminationControlMember2023-01-012023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembercountry:JP2023-01-012023-09-300001101302country:JP2023-01-012023-09-300001101302entg:MaterialsSciencesMembersrt:EuropeMember2023-01-012023-09-300001101302entg:MicrocontaminationControlMembersrt:EuropeMember2023-01-012023-09-300001101302entg:AdvancedMaterialsHandlingAMHMembersrt:EuropeMember2023-01-012023-09-300001101302srt:EuropeMember2023-01-012023-09-300001101302entg:SoutheastAsiaMemberentg:MaterialsSciencesMember2023-01-012023-09-300001101302entg:SoutheastAsiaMemberentg:MicrocontaminationControlMember2023-01-012023-09-300001101302entg:SoutheastAsiaMemberentg:AdvancedMaterialsHandlingAMHMember2023-01-012023-09-300001101302entg:SoutheastAsiaMember2023-01-012023-09-300001101302entg:MaterialsSciencesMembercountry:US2022-01-012022-12-310001101302entg:MaterialsSciencesMembercountry:US2022-01-012022-10-010001101302entg:MicrocontaminationControlMembercountry:US2022-01-012022-10-010001101302entg:MicrocontaminationControlMembercountry:US2022-01-012022-12-310001101302entg:AdvancedMaterialsHandlingAMHMembercountry:US2022-01-012022-10-010001101302entg:AdvancedMaterialsHandlingAMHMembercountry:US2022-01-012022-12-310001101302entg:IntersegmentSalesEliminationMembercountry:US2022-01-012022-10-010001101302entg:IntersegmentSalesEliminationMembercountry:US2022-01-012022-12-310001101302country:US2022-01-012022-12-310001101302country:US2022-01-012022-10-010001101302country:TWentg:MaterialsSciencesMember2022-01-012022-12-310001101302country:TWentg:MaterialsSciencesMember2022-01-012022-10-010001101302country:TWentg:MicrocontaminationControlMember2022-01-012022-10-010001101302country:TWentg:MicrocontaminationControlMember2022-01-012022-12-310001101302entg:AdvancedMaterialsHandlingAMHMembercountry:TW2022-01-012022-12-310001101302entg:AdvancedMaterialsHandlingAMHMembercountry:TW2022-01-012022-10-010001101302country:TWentg:IntersegmentSalesEliminationMember2022-01-012022-12-310001101302country:TW2022-01-012022-10-010001101302country:TW2022-01-012022-12-310001101302entg:MaterialsSciencesMembercountry:CN2022-01-012022-10-010001101302entg:MaterialsSciencesMembercountry:CN2022-01-012022-12-310001101302entg:MicrocontaminationControlMembercountry:CN2022-01-012022-12-310001101302entg:MicrocontaminationControlMembercountry:CN2022-01-012022-10-010001101302entg:AdvancedMaterialsHandlingAMHMembercountry:CN2022-01-012022-12-310001101302entg:AdvancedMaterialsHandlingAMHMembercountry:CN2022-01-012022-10-010001101302entg:IntersegmentSalesEliminationMembercountry:CN2022-01-012022-12-310001101302country:CN2022-01-012022-10-010001101302country:CN2022-01-012022-12-310001101302entg:MaterialsSciencesMembercountry:KR2022-01-012022-12-310001101302entg:MaterialsSciencesMembercountry:KR2022-01-012022-10-010001101302entg:MicrocontaminationControlMembercountry:KR2022-01-012022-10-010001101302entg:AdvancedMaterialsHandlingAMHMembercountry:KR2022-01-012022-10-010001101302entg:MicrocontaminationControlMembercountry:KR2022-01-012022-12-310001101302entg:IntersegmentSalesEliminationMembercountry:KR2022-01-012022-12-310001101302country:KR2022-01-012022-12-310001101302country:KR2022-01-012022-10-010001101302country:JPentg:MaterialsSciencesMember2022-01-012022-10-010001101302country:JPentg:MaterialsSciencesMember2022-01-012022-12-310001101302country:JPentg:MicrocontaminationControlMember2022-01-012022-10-010001101302entg:AdvancedMaterialsHandlingAMHMembercountry:JP2022-01-012022-10-010001101302country:JPentg:MicrocontaminationControlMember2022-01-012022-12-310001101302entg:AdvancedMaterialsHandlingAMHMembercountry:JP2022-01-012022-12-310001101302country:JPentg:IntersegmentSalesEliminationMember2022-01-012022-12-310001101302country:JP2022-01-012022-10-010001101302country:JP2022-01-012022-12-310001101302entg:MaterialsSciencesMembersrt:EuropeMember2022-01-012022-10-010001101302entg:MaterialsSciencesMembersrt:EuropeMember2022-01-012022-12-310001101302entg:MicrocontaminationControlMembersrt:EuropeMember2022-01-012022-10-010001101302entg:MicrocontaminationControlMembersrt:EuropeMember2022-01-012022-12-310001101302entg:AdvancedMaterialsHandlingAMHMembersrt:EuropeMember2022-01-012022-12-310001101302entg:AdvancedMaterialsHandlingAMHMembersrt:EuropeMember2022-01-012022-10-010001101302entg:IntersegmentSalesEliminationMembersrt:EuropeMember2022-01-012022-12-310001101302srt:EuropeMember2022-01-012022-12-310001101302srt:EuropeMember2022-01-012022-10-010001101302entg:SoutheastAsiaMemberentg:MaterialsSciencesMember2022-01-012022-10-010001101302entg:SoutheastAsiaMemberentg:MaterialsSciencesMember2022-01-012022-12-310001101302entg:SoutheastAsiaMemberentg:MicrocontaminationControlMember2022-01-012022-12-310001101302entg:SoutheastAsiaMemberentg:MicrocontaminationControlMember2022-01-012022-10-010001101302entg:SoutheastAsiaMemberentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-10-010001101302entg:SoutheastAsiaMemberentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-12-310001101302entg:SoutheastAsiaMemberentg:IntersegmentSalesEliminationMember2022-01-012022-12-310001101302entg:SoutheastAsiaMember2022-01-012022-12-310001101302entg:SoutheastAsiaMember2022-01-012022-10-010001101302entg:MaterialsSciencesMember2022-01-012022-12-310001101302entg:MicrocontaminationControlMember2022-01-012022-12-310001101302entg:AdvancedMaterialsHandlingAMHMember2022-01-012022-12-310001101302entg:IntersegmentSalesEliminationMember2022-01-012022-12-310001101302us-gaap:SubsequentEventMember2023-10-062023-10-060001101302us-gaap:SubsequentEventMember2023-10-312023-10-310001101302us-gaap:SubsequentEventMember2023-10-182023-10-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________________________________
FORM 10-Q
______________________________________________
(Mark One) | | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2023
OR | | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 001-32598
_______________________________________
Entegris, Inc.
(Exact name of registrant as specified in its charter)
_________________________________________ | | | | | | | | | | | | | | |
Delaware | | 41-1941551 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| | | |
129 Concord Road, | Billerica, | Massachusetts | | 01821 |
(Address of principal executive offices) | | (Zip Code) |
(978) 436-6500
(Registrant’s telephone number, including area code)
None
(Former name, former address and former fiscal year, if changed since last report)
_______________________________________
Securities registered pursuant to Section 12(b) of the Act: | | | | | | | | | | | | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common stock, $0.01 par value per share | | ENTG | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. | | | | | | | | | | | | | | | | | |
Large accelerated filer | | ý | Accelerated filer | | ☐ |
| | | |
Non-accelerated filer | | ¨ | Smaller reporting company | | ☐ |
| | | | | |
| | | Emerging growth company | | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ý
As of October 30, 2023, there were 150,158,883 shares of the registrant’s common stock outstanding.
ENTEGRIS, INC. AND SUBSIDIARIES
FORM 10-Q
TABLE OF CONTENTS
FOR THE QUARTER ENDED SEPTEMBER 30, 2023
| | | | | |
Description | Page |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities | |
| |
| |
| |
Cautionary Statements
This Quarterly Report on Form 10-Q contains “forward-looking statements.” The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements may include statements about supply chain matters; inflationary pressures; future period guidance or projections; the Company’s performance relative to its markets, including the drivers of such performance; market and technology trends, including the duration and drivers of any growth trends; the development of new products and the success of their introductions; the focus of the Company’s engineering, research and development projects; the Company’s ability to execute on our business strategies, including with respect to the Company’s expansion of its manufacturing presence in Taiwan and in Colorado Springs; the Company’s capital allocation strategy, which may be modified at any time for any reason, including share repurchases, dividends, debt repayments and potential acquisitions; the impact of the acquisitions and divestitures the Company has made and commercial partnerships the Company has established, including the acquisition of CMC Materials, Inc. (now known as CMC Materials LLC) (“CMC Materials”); trends relating to the fluctuation of currency exchange rates; future capital and other expenditures, including estimates thereof; the Company’s expected tax rate; the impact, financial or otherwise, of any organizational changes; the impact of accounting pronouncements; quantitative and qualitative disclosures about market risk; and other matters. These forward-looking statements are based on current management expectations and assumptions only as of the date of this Quarterly Report, are not guarantees of future performance and involve substantial risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, but are not limited to, weakening of global and/or regional economic conditions, generally or specifically in the semiconductor industry, which could decrease the demand for the Company’s products and solutions; the level of, and obligations associated with, the Company’s indebtedness, including the debts incurred in connection with the acquisition of CMC Materials; risks related to the acquisition and integration of CMC Materials, including unanticipated difficulties or expenditures relating thereto, the ability to achieve the anticipated synergies and value-creation contemplated by the acquisition of CMC Materials and the diversion of management time on transaction-related matters; raw material shortages, supply and labor constraints, price increases, inflationary pressures and rising interest rates;
operational, political and legal risks of the Company’s international operations; the Company’s dependence on sole source and limited source suppliers; the Company’s ability to meet rapid demand shifts; the Company’s ability to continue technological innovation and introduce new products to meet customers’ rapidly changing requirements; substantial competition; the Company’s concentrated customer base; the Company’s ability to identify, complete and integrate acquisitions, joint ventures, divestitures or other similar transactions; the Company’s ability to effectively implement any organizational changes; the Company’s ability to protect and enforce intellectual property rights; the impact of regional and global instabilities, hostilities and geopolitical uncertainty, including, but not limited to, the ongoing conflicts between Ukraine and Russia and between Israel and Hamas, as well as the global responses thereto; the increasing complexity of certain manufacturing processes; changes in government regulations of the countries in which the Company operates, including the imposition of tariffs, export controls and other trade laws and restrictions and changes to national security and international trade policy, especially as they relate to China; fluctuation of currency exchange rates; fluctuations in the market price of the Company’s stock; and other risk factors and additional information described in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including under the heading “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed on February 23, 2023, and in the Company’s other SEC filings. Except as required under the federal securities laws and the rules and regulations of the SEC, the Company undertakes no obligation to update publicly any forward-looking statements or information contained herein, which speak as of their respective dates.
PART 1. FINANCIAL INFORMATION
Item 1. Financial Statements
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
| | | | | | | | | | | |
(In thousands, except share and per share data) | September 30, 2023 | | December 31, 2022 |
ASSETS | | | |
Current assets: | | | |
Cash and cash equivalents | $ | 594,020 | | | $ | 561,559 | |
Restricted cash | — | | | 1,880 | |
Trade accounts and notes receivable, net of allowance for credit losses of $4,126 and $5,443 | 463,083 | | | 535,485 | |
Inventories, net | 662,169 | | | 812,815 | |
Deferred tax charges and refundable income taxes | 67,848 | | | 47,618 | |
Assets held-for-sale | 1,045,217 | | | 246,531 | |
Other current assets | 111,223 | | | 129,297 | |
Total current assets | 2,943,560 | | | 2,335,185 | |
Property, plant and equipment, net of accumulated depreciation of $869,951 and $770,093 | 1,406,357 | | | 1,393,337 | |
Other assets: | | | |
Right-of-use assets | 83,548 | | | 94,940 | |
Goodwill | 3,954,036 | | | 4,408,331 | |
Intangible assets, net of accumulated amortization of $771,786 and $636,872 | 1,368,363 | | | 1,841,955 | |
Deferred tax assets and other noncurrent tax assets | 30,211 | | | 28,867 | |
Other | 38,541 | | | 36,242 | |
Total assets | $ | 9,824,616 | | | $ | 10,138,857 | |
LIABILITIES AND EQUITY | | | |
Current liabilities: | | | |
Short-term debt, including current portion of long-term debt | $ | — | | | $ | 151,965 | |
Accounts payable | 139,637 | | | 172,488 | |
Accrued payroll and related benefits | 109,284 | | | 142,340 | |
Accrued interest payable | 65,195 | | | 25,571 | |
Liabilities held-for-sale | 139,270 | | | 10,637 | |
Other accrued liabilities | 166,258 | | | 160,873 | |
Income taxes payable | 63,515 | | | 98,057 | |
Total current liabilities | 683,159 | | | 761,931 | |
Long-term debt, excluding current maturities, net of unamortized discount and debt issuance costs of $113,003 and $140,107 | 5,425,496 | | | 5,632,928 | |
Pension benefit obligations and other liabilities | 44,627 | | | 54,090 | |
Deferred tax liabilities and other noncurrent tax liabilities | 231,698 | | | 391,192 | |
Long-term lease liability | 71,347 | | | 80,716 | |
| | | |
Equity: | | | |
Preferred stock, par value $.01; 5,000,000 shares authorized; none issued and outstanding as of September 30, 2023 and December 31, 2022 | — | | | — | |
Common stock, par value $.01; 400,000,000 shares authorized; issued and outstanding shares as of September 30, 2023: 150,357,237 and 150,154,837, respectively; issued and outstanding shares as of December 31, 2022: 149,339,486 and 149,137,086, respectively | 1,504 | | | 1,493 | |
Treasury stock, at cost: 202,400 shares held as of September 30, 2023 and December 31, 2022 | (7,112) | | | (7,112) | |
Additional paid-in capital | 2,283,823 | | | 2,205,325 | |
Retained earnings | 1,128,907 | | | 1,031,391 | |
Accumulated other comprehensive loss | (38,833) | | | (13,097) | |
Total equity | 3,368,289 | | | 3,218,000 | |
Total liabilities and equity | $ | 9,824,616 | | | $ | 10,138,857 | |
See the accompanying notes to condensed consolidated financial statements.
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended | | Nine months ended |
(In thousands, except per share data) | September 30, 2023 | | October 1, 2022 | | September 30, 2023 | | October 1, 2022 |
Net sales | $ | 888,239 | | | $ | 993,828 | | | $ | 2,711,635 | | | $ | 2,335,963 | |
Cost of sales | 521,165 | | | 622,157 | | | 1,558,710 | | | 1,344,075 | |
Gross profit | 367,074 | | | 371,671 | | | 1,152,925 | | | 991,888 | |
Selling, general and administrative expenses | 116,051 | | | 226,446 | | | 431,514 | | | 404,239 | |
Engineering, research and development expenses | 66,810 | | | 64,990 | | | 209,746 | | | 160,953 | |
Amortization of intangible assets | 51,239 | | | 65,346 | | | 163,493 | | | 90,491 | |
Goodwill impairment | 15,913 | | | — | | | 104,785 | | | — | |
Gain on termination of alliance agreement | — | | | — | | | (154,754) | | | — | |
Operating income | 117,061 | | | 14,889 | | | 398,141 | | | 336,205 | |
Interest expense | 77,820 | | | 84,150 | | | 244,874 | | | 129,027 | |
Interest income | (2,226) | | | (1,395) | | | (5,854) | | | (2,065) | |
Other expense, net | 10,243 | | | 12,852 | | | 13,309 | | | 27,373 | |
Income (loss) before income tax (benefit) expense | 31,224 | | | (80,718) | | | 145,812 | | | 181,870 | |
Income tax (benefit) expense | (2,127) | | | (7,015) | | | 2,851 | | | 30,377 | |
Equity in net loss of affiliates | 139 | | | — | | | 269 | | | — | |
Net income (loss) | $ | 33,212 | | | $ | (73,703) | | | $ | 142,692 | | | $ | 151,493 | |
| | | | | | | |
Basic earnings (loss) per common share | $ | 0.22 | | | $ | (0.50) | | | $ | 0.95 | | | $ | 1.08 | |
Diluted earnings (loss) per common share | $ | 0.22 | | | $ | (0.50) | | | $ | 0.95 | | | $ | 1.08 | |
| | | | | | | |
Weighted shares outstanding: | | | | | | | |
Basic | 150,127 | | 148,570 | | 149,793 | | 140,045 |
Diluted | 151,229 | | 148,570 | | 150,816 | | 140,892 |
See the accompanying notes to condensed consolidated financial statements.
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended | | Nine months ended |
(In thousands) | September 30, 2023 | | October 1, 2022 | | September 30, 2023 | | October 1, 2022 |
Net income (loss) | $ | 33,212 | | | $ | (73,703) | | | $ | 142,692 | | | $ | 151,493 | |
Other comprehensive loss, net of tax | | | | | | | |
Foreign currency translation adjustments | (9,174) | | | (37,461) | | | (23,451) | | | (48,603) | |
Pension liability adjustments | (33) | | | — | | | 4 | | | 73 | |
Interest rate swap - cash flow hedge, change in fair value - (loss) income, net of tax (benefit) expense of ($598) and ($667) for the three and nine months ended September 30, 2023 and $9,285 and $9,285 for the three and nine months ended October 1, 2022, respectively. | (2,050) | | | 30,743 | | | (2,289) | | | 30,743 | |
Other comprehensive loss | (11,257) | | | (6,718) | | | (25,736) | | | (17,787) | |
Comprehensive income (loss) | $ | 21,955 | | | $ | (80,421) | | | $ | 116,956 | | | $ | 133,706 | |
See the accompanying notes to condensed consolidated financial statements.
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(In thousands) | Common shares outstanding | | Common stock | | Treasury shares | | Treasury stock | | Additional paid-in capital | | Retained earnings | | Foreign currency translation adjustments | | Defined benefit pension adjustments | | Interest Rate Swap - Cash flow hedge | | Total |
Balance at December 31, 2021 | 135,719 | | | $ | 1,357 | | | 202 | | | $ | (7,112) | | | $ | 879,845 | | | $ | 879,776 | | | $ | (38,863) | | | $ | (1,222) | | | $ | — | | | $ | 1,713,781 | |
Shares issued under stock plans | 366 | | | 4 | | | — | | | — | | | (12,742) | | | — | | | — | | | — | | | — | | | (12,738) | |
Share-based compensation expense | — | | | — | | | — | | | — | | | 9,285 | | | — | | | — | | | — | | | — | | | 9,285 | |
| | | | | | | | | | | | | | | | | | | |
Dividends declared ($0.10 per share) | — | | | — | | | — | | | — | | | — | | | (13,660) | | | — | | | — | | | — | | | (13,660) | |
Pension liability adjustment | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 73 | | | — | | | 73 | |
Foreign currency translation | — | | | — | | | — | | | — | | | — | | | — | | | (2,128) | | | — | | | — | | | (2,128) | |
Net income | — | | | — | | | — | | | — | | | — | | | 125,705 | | | — | | | — | | | — | | | 125,705 | |
Balance at April 2, 2022 | 136,085 | | | 1,361 | | | 202 | | | (7,112) | | | 876,388 | | | 991,821 | | | (40,991) | | | (1,149) | | | — | | | 1,820,318 | |
Shares issued under stock plans | 88 | | | 1 | | | | | — | | | 5,397 | | | — | | | — | | | — | | | — | | | 5,398 | |
Share-based compensation expense | — | | | — | | | — | | | — | | | 10,182 | | | — | | | — | | | — | | | — | | | 10,182 | |
| | | | | | | | | | | | | | | | | | | |
Dividends declared ($0.10 per share) | — | | | — | | | — | | | — | | | — | | | (13,661) | | | — | | | — | | | — | | | (13,661) | |
| | | | | | | | | | | | | | | | | | | |
Foreign currency translation | — | | | — | | | — | | | — | | | — | | | — | | | (9,014) | | | — | | | — | | | (9,014) | |
Net income | — | | | — | | | — | | | — | | | — | | | 99,491 | | | — | | | — | | | — | | | 99,491 | |
Balance at July 2, 2022 | 136,173 | | | $ | 1,362 | | | 202 | | | $ | (7,112) | | | $ | 891,967 | | | $ | 1,077,651 | | | $ | (50,005) | | | $ | (1,149) | | | — | | | $ | 1,912,714 | |
Shares issued under stock plans | 137 | | | 1 | | | | | — | | | (4,644) | | | — | | | — | | | — | | | — | | | (4,643) | |
Share-based compensation expense | — | | | — | | | — | | | — | | | 38,077 | | | — | | | — | | | — | | | — | | | 38,077 | |
Issuance of common stock in connection with CMC Materials acquisition | 12,927 | | | 129 | | | — | | | — | | | 1,265,561 | | | — | | | — | | | — | | | — | | | 1,265,690 | |
Dividends declared ($0.10 per share) | — | | | — | | | — | | | — | | | — | | | (15,100) | | | — | | | — | | | — | | | (15,100) | |
| | | | | | | | | | | | | | | | | | | |
Interest Rate Swap - Cash flow hedge | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 30,743 | | | 30,743 | |
Foreign currency translation | — | | | — | | | — | | | — | | | — | | | — | | | (37,461) | | | — | | | — | | | (37,461) | |
Net loss | — | | | — | | | — | | | — | | | — | | | (73,703) | | | — | | | — | | | — | | | (73,703) | |
Balance at October 1, 2022 | 149,237 | | | $ | 1,492 | | | 202 | | | $ | (7,112) | | | $ | 2,190,961 | | | $ | 988,848 | | | $ | (87,466) | | | $ | (1,149) | | | $ | 30,743 | | | $ | 3,116,317 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(In thousands) | Common shares outstanding | | Common stock | | Treasury shares | | Treasury stock | | Additional paid-in capital | | Retained earnings | | Foreign currency translation adjustments | | Defined benefit pension adjustments | | Interest Rate Swap - Cash flow hedge | | Total |
Balance at December 31, 2022 | 149,339 | | | $ | 1,493 | | | 202 | | | $ | (7,112) | | | $ | 2,205,325 | | | $ | 1,031,391 | | | $ | (49,083) | | | $ | (83) | | | $ | 36,069 | | | $ | 3,218,000 | |
Shares issued under stock plans | 530 | | | 6 | | | — | | | — | | | 8,981 | | | — | | | — | | | — | | | — | | | 8,987 | |
Share-based compensation expense | — | | | — | | | — | | | — | | | 30,678 | | | — | | | — | | | — | | | — | | | 30,678 | |
Dividends declared ($0.10 per share) | — | | | — | | | — | | | — | | | — | | | (15,092) | | | — | | | — | | | — | | | (15,092) | |
Interest Rate Swap - Cash flow hedge | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (9,955) | | | (9,955) | |
Pension liability adjustment | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 37 | | | — | | | 37 | |
Foreign currency translation | — | | | — | | | — | | | — | | | — | | | — | | | 23,734 | | | — | | | — | | | 23,734 | |
Net loss | — | | | — | | | — | | | — | | | — | | | (88,166) | | | — | | | — | | | — | | | (88,166) | |
Balance at April 1, 2023 | 149,869 | | | 1,499 | | | 202 | | | (7,112) | | | 2,244,984 | | | 928,133 | | | (25,349) | | | (46) | | | 26,114 | | | 3,168,223 | |
Shares issued under stock plans | 439 | | | 4 | | | — | | | — | | | 18,130 | | | — | | | — | | | — | | | — | | | 18,134 | |
Share-based compensation expense | — | | | — | | | — | | | — | | | 11,458 | | | — | | | — | | | — | | | — | | | 11,458 | |
Dividends declared ($0.10 per share) | — | | | — | | | — | | | — | | | — | | | (14,961) | | | — | | | — | | | — | | | (14,961) | |
Interest Rate Swap - Cash flow hedge | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 9,716 | | | 9,716 | |
Pension liability adjustment | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
Foreign currency translation | — | | | — | | | — | | | — | | | — | | | — | | | (38,011) | | | — | | | — | | | (38,011) | |
Net Income | — | | | — | | | — | | | — | | | — | | | 197,646 | | | — | | | — | | | — | | | 197,646 | |
Balance at July 1, 2023 | 150,308 | | | $ | 1,503 | | | 202 | | | $ | (7,112) | | | $ | 2,274,572 | | | $ | 1,110,818 | | | $ | (63,360) | | | $ | (46) | | | $ | 35,830 | | | $ | 3,352,205 | |
Shares issued under stock plans | 49 | | | 1 | | | — | | | — | | | (1,029) | | | — | | | — | | | — | | | — | | | (1,028) | |
Share-based compensation expense | — | | | — | | | — | | | — | | | 10,280 | | | — | | | — | | | — | | | — | | | 10,280 | |
Dividends declared ($0.10 per share) | — | | | — | | | — | | | — | | | — | | | (15,123) | | | — | | | — | | | — | | | (15,123) | |
Interest Rate Swap - Cash flow hedge | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (2,050) | | | (2,050) | |
Pension liability adjustment | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (33) | | | — | | | (33) | |
Foreign currency translation | — | | | — | | | — | | | — | | | — | | | — | | | (9,174) | | | — | | | — | | | (9,174) | |
Net Income | — | | | — | | | — | | | — | | | — | | | 33,212 | | | — | | | — | | | — | | | 33,212 | |
Balance at September 30, 2023 | 150,357 | | | $ | 1,504 | | | 202 | | | $ | (7,112) | | | $ | 2,283,823 | | | $ | 1,128,907 | | | $ | (72,534) | | | $ | (79) | | | $ | 33,780 | | | $ | 3,368,289 | |
See the accompanying notes to condensed consolidated financial statements.
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
| | | | | | | | | | | |
| Nine months ended |
(In thousands) | September 30, 2023 | | October 1, 2022 |
Operating activities: | | | |
Net income | $ | 142,692 | | | $ | 151,493 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | |
Depreciation | 130,125 | | | 93,489 | |
Amortization | 163,493 | | | 90,491 | |
Share-based compensation expense | 52,416 | | | 57,544 | |
Charge for fair value mark-up of acquired inventory sold | — | | | 61,932 | |
Provision for deferred income taxes | (95,366) | | | (56,964) | |
Impairment of goodwill | 104,785 | | | — | |
Loss on extinguishment of debt | 10,862 | | | 2,235 | |
Loss from sale of business and held-for-sale | 28,579 | | | — | |
Gain on termination of alliance agreement | (154,754) | | | — | |
Charge for excess and obsolete inventory | 29,314 | | | 17,582 | |
Amortization of debt issuance costs | 16,718 | | | 9,211 | |
Other | 21,801 | | | 29,459 | |
Changes in operating assets and liabilities: | | | |
Trade accounts and notes receivable | (295) | | | (34,378) | |
Inventories | 63,340 | | | (180,335) | |
Accounts payable and accrued liabilities | 4,345 | | | 83,307 | |
Other current assets | 1,644 | | | (4,248) | |
Income taxes payable and refundable income taxes | (36,774) | | | (15,637) | |
Other | (4,013) | | | 15,049 | |
Net cash provided by operating activities | 478,912 | | | 320,230 | |
Investing activities: | | | |
Acquisition of property, plant and equipment | (328,182) | | | (318,836) | |
Acquisition of businesses, net of cash acquired | — | | | (4,474,925) | |
Proceeds from sale of business
| 134,286 | | | — | |
Proceeds from termination of alliance agreement | 169,251 | | | — | |
Other | 1,919 | | | 1,124 | |
Net cash used in investing activities | (22,726) | | | (4,792,637) | |
Financing activities: | | | |
Proceeds from revolving credit facility and short-term debt | — | | | 476,000 | |
Payments of revolving credit facility and short-term debt | (135,000) | | | (271,000) | |
Proceeds from long-term debt | 217,449 | | | 4,940,753 | |
Payments of long-term debt | (468,950) | | | (145,000) | |
| | | |
Payments for debt issuance costs | (3,475) | | | (99,489) | |
Payments for dividends | (45,202) | | | (42,413) | |
Issuance of common stock | 37,633 | | | 10,764 | |
| | | |
Taxes paid related to net share settlement of equity awards | (11,540) | | | (22,747) | |
| | | |
Other | (923) | | | (859) | |
Net cash (used in) provided by financing activities | (410,008) | | | 4,846,009 | |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (15,597) | | | (21,500) | |
Increase in cash, cash equivalents and restricted cash | 30,581 | | | 352,102 | |
Cash, cash equivalents and restricted cash at beginning of period | 563,439 | | | 402,565 | |
Cash, cash equivalents and restricted cash at end of period | $ | 594,020 | | | $ | 754,667 | |
See the accompanying notes to condensed consolidated financial statements.
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
(Unaudited)
| | | | | | | | | | | |
Supplemental Cash Flow Information | Nine months ended |
(In thousands) | September 30, 2023 | | October 1, 2022 |
Non-cash transactions: | | | |
| | | |
| | | |
Equipment purchases in accounts payable | 35,684 | | | 19,362 | |
Dividend payable | 628 | | | 666 | |
Equity consideration on acquisition of CMC Materials | — | | | 1,265,690 | |
Schedule of interest and income taxes paid: | | | |
Interest paid less capitalized interest | 292,416 | | | 22,917 | |
Income taxes paid, net of refunds received | 129,474 | | | 96,729 | |
See the accompanying notes to condensed consolidated financial statements.
ENTEGRIS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations Entegris, Inc. (“Entegris”, “the Company”, “us”, “we”, or “our”) is a leading supplier of advanced materials and process solutions for the semiconductor and other high-technology industries.
Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. Intercompany profits, transactions and balances have been eliminated in consolidation.
Use of Estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, particularly receivables, inventories, property, plant and equipment, right-of-use assets, goodwill, intangibles, accrued expenses, short-term and long-term lease liability, income taxes and related accounts, and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Basis of Presentation The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States and contain all adjustments considered necessary, and are of a normal recurring nature, to present fairly the financial position as of September 30, 2023 and December 31, 2022, and the results of operations and comprehensive income for the three and nine months ended September 30, 2023 and October 1, 2022, the equity statements as of and for the three and nine months ended September 30, 2023 and October 1, 2022, and cash flows for the nine months ended September 30, 2023 and October 1, 2022.
The condensed consolidated financial statements and accompanying notes are presented as permitted by Form 10-Q and do not contain certain information included in the Company’s annual consolidated financial statements and notes. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with Management’s Discussion and Analysis and consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the full year.
In the third quarter of 2023, in order to align its segment financial reporting with a change in its business structure, the Company realigned its segments. Following the segment realignment, the Company’s three reportable segments are as follows (1) Materials Solutions, (2) Microcontamination Control, and (3) Advanced Materials Handling. The current interim and succeeding annual periods will disclose the reportable segments with prior periods recast to reflect the change.
Recently Adopted Accounting Pronouncements The Company currently has no material recently adopted accounting pronouncements.
Recently Issued Accounting Pronouncements The Company currently has no material recent accounting pronouncements yet to be adopted.
2. REVENUES
The following table provides information about current contract liabilities from contracts with customers. The contract liabilities are included in other accrued liabilities balance in the condensed consolidated balance sheet. | | | | | | | | | | | |
| Nine months ended |
(In thousands) | September 30, 2023 | | October 1, 2022 |
Balance at beginning of period | $ | 60,476 | | | $ | 23,050 | |
Revenue recognized that was included in the contract liability balance at the beginning of the period | (32,736) | | | (26,444) | |
Increases due to cash received, excluding amounts recognized as revenue during the period | 56,145 | | | 40,725 | |
Contract liabilities included as part of disposition | (6,226) | | | — | |
Additions due to acquisitions | — | | | 11,108 | |
Balance at end of period | $ | 77,659 | | | $ | 48,439 | |
3. GOODWILL IMPAIRMENT
During the first quarter of 2023, while the criteria had not been met to classify the reporting unit as held for sale, the Company was exploring market interest in a potential sale of the Electronic Chemicals (“EC”) reporting unit within what is now the Materials Solutions segment (the segment resulting from combining the Advanced Planarization Solutions and the Specialty Chemicals and Engineered Materials segments). In connection with the sale process, management determined that certain impairment indicators were present and evaluated goodwill, intangible assets, and long-lived assets for impairment in connection with the quarter ending April 1, 2023.
Long-lived assets, including finite-lived intangible assets
The Company compared the estimated undiscounted future cash flows generated by the asset group to the carrying amount of the asset group for the reporting unit and determined that the undiscounted cash flows were expected to exceed the carrying value on a held and used basis, therefore no impairment was recorded on the long-lived asset or finite-lived intangible assets. The Company considered if the triggering event would cause a potential change to the useful life of the assets and did not consider a modification to the useful life necessary.
Goodwill
The Company compared the reporting unit’s fair value to its carrying amount, including goodwill, as of April 1, 2023. As the reporting unit’s carrying amount, including goodwill, exceeded its fair value, the Company determined the goodwill was impaired and recorded an impairment of $88.9 million during the three months ended April 1, 2023 and an incremental impairment loss was recorded with the finalization of certain purchase price adjustments of $15.9 million during the three months ended September 30, 2023. The impairment is classified as goodwill impairment in the Company's condensed consolidated statement of operations. The goodwill impairment is non-taxable. The fair value of the reporting unit was determined using a market-based approach, which was aligned to the expected selling price. We consider this a Level 3 measurement in the fair value hierarchy.
Following the end of our third quarter of fiscal 2023, on October 2, 2023, we completed the sale of the EC reporting unit, which reported into the Materials Solutions segment, see Note 5.
4. ACQUISITION
CMC Materials
On July 6, 2022 (the “Closing Date”), the Company completed its acquisition of CMC Materials, Inc. (now known as CMC Materials LLC) (“CMC Materials”) for approximately $6.0 billion in cash and stock (the “Acquisition”) pursuant to an Agreement and Plan of Merger, dated as of December 14, 2021 (the “Acquisition Agreement”). As a result of the Acquisition, CMC Materials became a wholly owned subsidiary of the Company. The Acquisition was accounted for under the acquisition method of accounting and the results of operations of CMC Materials are included in the Company's condensed consolidated financial statements as of and since July 6, 2022. CMC Materials reports into the Materials Solutions segment (the segment resulting from combining the Advanced Planarization Solutions and the Specialty Chemicals and Engineered Materials segments) of the Company. Direct costs of $31.9 million and $39.3 million associated with the acquisition of CMC Materials, consisting primarily of professional and consulting fees, were expensed as incurred in the three and nine months ended
October 1, 2022, respectively. These costs are classified as selling, general and administrative expense in the Company's condensed consolidated statement of operations.
CMC Materials is a global supplier of consumable materials, primarily to semiconductor manufacturers. CMC Materials’ products play a critical role in the production of advanced semiconductor devices, helping to enable the manufacture of smaller, faster and more complex devices by its customers. The acquisition broadened the Company’s solutions set and enables the Company to bring to market a broader array of innovative and high-value solutions, at a faster pace, to help customers improve productivity, performance and total cost of ownership.
The purchase price of CMC Materials consisted of the following:
| | | | | |
(In thousands): | |
Cash paid to CMC Materials’ shareholders | $ | 3,836,983 | |
Stock paid to CMC Materials’ shareholders | 1,265,690 | |
Repayment of CMC Materials’ indebtedness | 918,578 | |
Total purchase price | 6,021,251 | |
Less cash and cash equivalents acquired | 280,636 | |
Total purchase price, net of cash acquired | $ | 5,740,615 | |
Under the terms of the Acquisition Agreement, the Company paid $133.00 per share for all outstanding shares of CMC Materials (excluding treasury shares). In addition, the Company settled all outstanding share-based compensation awards held by CMC Materials’ employees at the same per share price except for certain unvested performance units that were replaced by the Company’s restricted share units. The acquisition method of accounting requires the Company to include the amount associated with pre-combination service as purchase price for the acquisition, reflected in the table immediately above.
The Acquisition was funded with existing cash balances as well as funds raised by the Company through the issuance of debt in the form of a new term loan facility in the aggregate principal amount of $2,495.0 million, senior secured notes due 2029 in an aggregate principal amount of $1,600.0 million, senior unsecured notes due 2030 in an aggregate principal amount of $895.0 million, and a 364-Day Bridge Credit Facility in the aggregate principal amount of $275.0 million.
The following table summarizes the allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed at the date of the Acquisition:
| | | | | | | | |
(In thousands): | July 6, 2022 | |
Cash and cash equivalents | $ | 280,636 | | |
Accounts receivable and other current assets | 207,472 | | |
Inventory | 256,598 | | |
Property, plant and equipment | 537,387 | | |
Identifiable intangible assets | 1,736,219 | | |
Other noncurrent assets | 39,725 | | |
Current liabilities | (211,417) | | |
Deferred tax liabilities and other noncurrent liabilities | (452,805) | | |
Net assets acquired | 2,393,815 | | |
Goodwill | 3,627,436 | | |
Total purchase price | $ | 6,021,251 | | |
The final valuation of assets acquired and liabilities assumed in connection with the Acquisition was completed in the second quarter of 2023.
The fair value of acquired inventories was $256.6 million and was valued at the estimated selling price less the cost of disposal and reasonable profit for the selling effort. The fair value write-up of acquired finished goods inventory was $61.9 million. This amount was recorded as an incremental cost of sales charge, amortized over the expected turn of the acquired inventory, during the year ended December 31, 2022.
The fair value of acquired property, plant and equipment of $537.4 million is valued at its fair value assuming held and used, unless market data was available supporting the fair value.
The Company recognized the following intangible assets as part of the acquisition of CMC Materials and finite-lived assets are amortized on a straight-line basis:
| | | | | | | | | | | |
(In thousands) | Amount | | Weighted average life in years |
Developed technology | $ | 1,043,000 | | | 7.3 |
Trademarks and trade names | 236,600 | | | 14.9 |
Customer relationships | 414,300 | | | 18.3 |
In-process research and development (1) | 31,400 | | | |
Other | 10,919 | | | 1.0 |
| $ | 1,736,219 | | | 11.0 |
(1) In-process research and development assets are treated as indefinite-lived until the completion or abandonment of the associated research and development project, at which time the appropriate useful lives would be determined.
The fair value of acquired identifiable finite intangible assets was determined using an income method, which utilizes discounted cash flows to identify the fair value of each of the identifiable intangible assets. The Company normally utilizes the “income method,” which starts with a forecast of all of the expected future net cash flows attributable to the subject intangible asset. These cash flows are then adjusted to present value by applying an appropriate discount rate that reflects the risk factors associated with the cash flow streams. Depending on the asset valued, the key assumptions included one or more of the following: (1) future revenue growth rates, (2) future gross margin, (3) future selling, general and administrative expenses, (4) royalty rates, and (5) discount rates. The valuations were based on the information that was available as of the acquisition date and the expectations and assumptions that have been deemed reasonable by the Company’s management. There are inherent uncertainties and management judgment required in these determinations. The fair value measurements of the assets acquired and liabilities assumed were based on valuations involving significant unobservable inputs, or Level 3 in the fair value hierarchy.
The purchase price of CMC Materials exceeded the fair value of the net of the acquisition-date amounts of the identifiable assets acquired and the liabilities assumed by $3,627.4 million. Cash flows used to determine the purchase price included strategic and synergistic benefits (investment value) specific to the Company, which resulted in a purchase price in excess of the fair value of identifiable net assets. The purchase price also included the fair values of other assets that were not identifiable, not separately recognizable under accounting rules (e.g., assembled workforce) or of immaterial value in addition to a going-concern element that represents the Company's ability to earn a higher rate of return on the group of assets than would be expected on the separate assets as determined during the valuation process. This additional investment value resulted in goodwill. No amount of goodwill is expected to be deductible for tax purposes.
Pro Forma Results (Unaudited)
The following unaudited pro forma financial information presents the combined results of operations of the Company as if the acquisition of CMC Materials had occurred January 1, 2021. The unaudited pro forma financial information is not necessarily indicative of what the Company’s condensed consolidated results of operations actually would have been had the acquisition occurred at the beginning of each year. In addition, the unaudited pro forma financial information does not attempt to project the future results of operations of the combined company. The pro forma information does not include any potential revenue enhancements, cost synergies or other operating efficiencies that could result from the acquisition.
| | | | | | | | | | | | | | | | | | | |
| | Three months ended | | | Nine months ended |
(In thousands, except share data) | | | October 1, 2022 | | | | October 1, 2022 |
Net sales | | | $ | 993,828 | | | | | $ | 2,974,781 | |
Net income | | | 63,940 | | | | | 234,621 | |
| | | | | | | |
Per share amounts: | | | | | | | |
Net income per common share - basic | | | $ | 0.43 | | | | | $ | 1.58 | |
Net income per common share - diluted | | | $ | 0.43 | | | | | $ | 1.56 | |
The unaudited pro forma financial information above gives effect to the following:
•The elimination of transactions between Entegris and CMC Materials, which upon completion of the Acquisition would be considered intercompany. This reflects the elimination of intercompany sales and associated intercompany accounts.
•Incremental amortization and depreciation expense related to the estimated fair value of identifiable intangible assets and property, plant and equipment from the purchase price allocation.
•Interest expense on the new debt raised to fund in part the consideration paid to effect the Acquisition using the effective interest rates.
•The elimination of interest expense, net of the one-time gain on the termination of two swap instruments which were terminated on June 24, 2022 in connection with the repayment of CMC Materials’ debt upon completion of the Acquisition.
•The elimination of interest expense associated with the repayment of the $145.0 million senior secured term loan facility due 2025.
•The amortization of deferred financing costs and original issue discount associated with the aggregate new debt facilities.
•Transaction and integration costs directly attributable to the Acquisition were reclassed as of the beginning of the comparable prior annual reporting period.
•The income tax effect of the transaction accounting adjustments related to the Acquisition calculated using a blended statutory income tax rate of 22.5%.
•The incremental pro forma stock-based compensation expense for accelerated vesting upon the change in control for stock options, restricted stock units, restricted stock shares, phantom units, and other deferred restricted stock units.
•The additional cost of goods sold recognized in connection with the write-up of acquired finished goods inventory of $61.9 million. The write-up is recognized in cost of sales as the inventory is sold, which for purposes of these pro forma financial statements is assumed to occur within the first quarter after the Acquisition and is non-recurring in nature.
5. ASSET HELD-FOR-SALE AND DIVESTITURE
Asset Held-For-Sale - PIM
On October 11, 2022, the Company announced entry into a definitive agreement to sell its Pipeline and Industrials Materials (“PIM”) business, which became part of the Company with the acquisition of CMC Materials, to Infineum USA L.P. (“Infineum”). The PIM business specializes in the manufacture and sale of drag reducing agents and a range of valve maintenance products and services, and reports into the Materials Solutions segment (the segment resulting from combining the Advanced Planarization Solutions and the Specialty Chemicals and Engineered Materials segments) of the Company. Effective February 10, 2023, the Company terminated the definitive agreement. In accordance with the terms of the agreement, the Company received a $12.0 million termination fee from Infineum in the first quarter of 2023 and incurred a transaction adviser fee of $1.1 million. The net amount of $10.9 million is recorded in Other expense, net in the condensed consolidated statement of operations. At the time of the termination, the transaction had not received clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”).
During the fourth quarter of 2022, the related assets and liabilities were classified as held-for-sale in the Company’s consolidated balance sheet and measured at the lower of their carrying amount or fair value less cost to sell. The assets and liabilities continue to be classified as held-for-sale at September 30, 2023.
The planned disposition of the PIM business did not meet the criteria to be classified as a discontinued operation in the Company’s financial statements since the disposition did not represent a strategic shift that had, or will have, a major effect on the Company’s operations and financial results.
PIM Assets-held-for sale comprise the following as of September 30, 2023:
| | | | | | | | |
(In thousands) | | |
Assets: | | September 30, 2023 |
Current assets | | $ | 49,277 | |
Property, Plant and Equipment, net | | 113,305 | |
Intangible assets, net | | 76,692 | |
Goodwill | | 12,707 | |
Other assets | | 1,364 | |
Total assets-held-for sale | | $ | 253,345 | |
| | |
Liabilities: | | |
Accounts payable | | $ | 5,675 | |
Accrued expenses | | 7,978 | |
Long-term liabilities | | 1,959 | |
Total liabilities-held-for sale | | $ | 15,612 | |
Income before income taxes attributable to the PIM business was $12.0 million and $33.3 million for the three and nine months ended September 30, 2023, respectively.
Asset held-for-sale - EC Business
On May 10, 2023, the Company announced entry into a definitive agreement to sell its Electronic Chemicals (“EC”) business, which became part of the Company with the acquisition of CMC Materials, to FUJIFILM Holdings America Corporation for approximately $700.0 million, subject to customary adjustments with respect to cash, working capital, indebtedness and transaction expenses. The EC business specializes in purification, formulation, blending, packaging and distribution of high-purity process chemicals used within the semiconductor and microelectronic manufacturing processes. In connection with the held-for-sale classification, upon the remeasurement of the disposal group to its fair value, less cost to sell, we recognized a loss on the assets held-for-sale of $13.6 million as loss on held for sale for the three months ended July 1, 2023 and a loss of $15.9 million on impairment of goodwill for the three months ended September 30, 2023. The loss on assets held-for-sale are included in Selling, general and administrative expenses and the goodwill impairment is included in goodwill impairment in the condensed consolidated statement of operations.
The disposition of the EC business did not meet the criteria to be classified as a discontinued operation in the Company’s financial statements since the disposition did not represent a strategic shift that had, or will have, a major effect on the Company’s operations and financial results.
EC Assets-held-for sale comprise the following as of September 30, 2023:
| | | | | | | | |
(In thousands) | | |
Assets: | | September 30, 2023 |
Current assets | | $ | 92,563 | |
Property, Plant and Equipment, net | | 177,020 | |
Intangible assets, net | | 263,686 | |
Goodwill | | 250,638 | |
Other assets | | 7,965 | |
Total assets-held-for sale | | $ | 791,872 | |
| | |
Liabilities: | | |
Accounts payable | | $ | 18,975 | |
Accrued expenses | | 15,255 | |
Long-term liabilities | | 89,428 | |
Total liabilities-held-for sale | | $ | 123,658 | |
(Income)/Loss before income taxes attributable to the EC business was ($0.9) million and $85.7 million for the three and nine months ended September 30, 2023. The loss before income taxes attributed to the EC business for the three months ended September 30, 2023 includes incremental goodwill impairment of $15.9 million. The loss before income taxes attributable to the EC business for the nine months ended September 30, 2023 includes total goodwill impairment charges of $104.8 million and loss on assets held-for-sale of $13.6 million for expected transaction expenses.
On October 2, 2023, following the end of our third quarter of 2023, the Company completed the sale of the EC business. The Company received gross cash proceeds of $737.1 million, or net proceeds of $694.3 million, which includes cash sold of $42.8 million, which remains subject to customary final post-closing adjustments. The Company intends to use the proceeds of this transaction for early repayment of debt.
Divestiture - QED
During the first quarter of 2023, the Company announced entry into a definitive agreement to sell QED Technologies International, Inc. (“QED”), which offers magnetorheological finishing polishing and subaperture stitching interferometry metrology manufacturing solutions to Quad-C Management, Inc. QED was a part of what is now the Materials Solutions segment (the segment resulting from combining the Advanced Planarization Solutions and the Specialty Chemicals and Engineered Materials segments) and became part of the Company with the acquisition of CMC Materials.
The Company completed the divestiture of QED on March 1, 2023 and received proceeds of $134.3 million after adjustments with respect to cash, working capital, indebtedness and transaction expenses. The disposition of QED did not meet the criteria to be classified as a discontinued operation in the Company’s financial statements since the disposition did not represent a strategic shift that had a major effect on the Company’s operations and financial results. The following table summarizes the fair value of the sale proceeds received in connection with the divestiture, which are subject to further post-closing adjustment:
| | | | | | | | |
(In thousands) | | March 1, 2023 |
Fair value of sale consideration | | $ | 137,500 | |
Final working capital adjustment | | 1,031 | |
Cash transferred to the buyer on the closing balance sheet | | (1,465) | |
Direct costs to sell | | (2,780) | |
Fair value of sale consideration | | $ | 134,286 | |
The carrying amount of net assets associated with the QED business was approximately $149.2 million. The major classes of assets and liabilities sold consisted of the following:
| | | | | | | | |
(In thousands) | | |
Assets: | | March 1, 2023 |
Current assets | | $ | 19,219 | |
Property, plant and equipment, net | | 2,663 | |
Goodwill | | 90,005 | |
Intangible assets, net | | 48,661 | |
Other assets | | 842 | |
Total assets | | $ | 161,390 | |
| | |
Liabilities: | | |
Accounts payable | | $ | 1,340 | |
Accrued expenses | | 8,750 | |
Long-term liabilities | | 2,067 | |
Total liabilities | | $ | 12,157 | |
| | |
As a result of the QED divestiture, the Company recognized a pre-tax loss of $14.9 million presented in selling, general and administrative expenses on the condensed consolidated statements of operations for the nine months ended September 30, 2023. The Company recorded an income tax benefit associated with the QED divestiture of approximately $6.8 million.
Termination - Alliance Agreement
On June 5, 2023, the Company announced the termination of the Alliance Agreement (the “Alliance Agreement”) between the Company and MacDermid Enthone Inc., a global business unit of Element Solutions Inc (“MacDermid Enthone”). Under the Alliance Agreement, Entegris had been granted the exclusive right to distribute MacDermid Enthone's Viaform products, subject to certain conditions. In connection with the termination of the Alliance Agreement, Entegris received a payment of $170.0 million on June 2, 2023 and will receive $30.0 million payable upon completion of customer transitions, subject to certain adjustments. The Company recognized a pre-tax gain of $154.8 million presented in gain on termination of alliance agreement on the condensed consolidated statements of operations for the three and nine months ended September 30, 2023, respectively.
6. RESTRICTED CASH
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheet that sum to the total of the same amounts shown in the condensed consolidated statement of cash flows.
| | | | | | | | | | | |
(In thousands) | September 30, 2023 | | December 31, 2022 |
Cash and cash equivalents | $ | 594,020 | | | $ | 561,559 | |
Restricted cash | — | | | 1,880 | |
Total cash, cash equivalents and restricted cash | $ | 594,020 | | | $ | 563,439 | |
The restricted cash represents cash held in a “Rabbi” trust. Prior to the acquisition of CMC Materials, CMC Materials’ change in control severance protection agreements required CMC Materials to establish a Rabbi trust prior to a change in control and fully fund the trust to cover all the severance benefits that may become payable under the agreements. The Company had no restricted cash as of September 30, 2023.
7. INVENTORIES
Inventories consist of the following:
| | | | | | | | | | | |
(In thousands) | September 30, 2023 | | December 31, 2022 |
Raw materials | $ | 278,184 | | | $ | 337,576 | |
Work-in-process | 51,596 | | | 60,182 | |
Finished goods (1) | 332,389 | | | 415,057 | |
Total inventories, net | $ | 662,169 | | | $ | 812,815 | |
(1) Includes consignment inventories held by customers of $21.3 million and $46.2 million at September 30, 2023 and December 31, 2022, respectively.
8. GOODWILL AND INTANGIBLE ASSETS
Goodwill activity for each of the Company’s reportable segments that carry goodwill, Materials Solutions (“MS”), Microcontamination Control (“MC”), and Advanced Materials Handling (“AMH”), was as follows at December 31, 2022 and September 30, 2023: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(In thousands) | MS | | MC | | AMH | | | Total | | |
December 31, 2022 | $ | 4,092,141 | | | $ | 242,088 | | | $ | 74,102 | | | | $ | 4,408,331 | | | |
| | | | | | | | | | |
Goodwill impairment | (104,785) | | | — | | | — | | | | (104,785) | | | |
Disposition of business | (90,005) | | | — | | | — | | | | (90,005) | | | |
Purchase accounting adjustments | (1,021) | | | — | | | — | | | | (1,021) | | | |
| | | | | | | | | | |
Assets held-for-sale | (254,524) | | | — | | | — | | | | (254,524) | | | |
Foreign currency translation | (43) | | | (3,917) | | | — | | | | (3,960) | | | |
September 30, 2023 | $ | 3,641,763 | | | $ | 238,171 | | | $ | 74,102 | | | | $ | 3,954,036 | | | |
The changes in our goodwill balance of $454.3 million reflect (1) the goodwill impairment of our EC reporting unit of $104.8 million, as described in Note 3, (2) the sale of the QED business and related goodwill of that business of $90.0 million, see Note 5, (3) purchase accounting adjustments of $1.0 million, (4) goodwill reclassified to asset held-for-sale of $254.5 million related to the PIM and EC businesses as described in Note 5 and (5) foreign currency translation of $4.0 million.
Identifiable intangible assets at September 30, 2023 and December 31, 2022 consist of the following: | | | | | | | | | | | | | | | | | |
September 30, 2023 |
(In thousands) | Gross carrying amount | | Accumulated amortization | | Net carrying value |
Developed technology | $ | 1,262,647 | | | $ | 421,703 | | | $ | 840,944 | |
Trademarks and trade names | 172,260 | | | 35,395 | | | 136,865 | |
Customer relationships | 673,718 | | | 294,056 | | | 379,662 | |
In-process research and development (1) | 7,600 | | | — | | | 7,600 | |
Other | 23,924 | | | 20,632 | | | 3,292 | |
| $ | 2,140,149 | | | $ | 771,786 | | | $ | 1,368,363 | |
| | | | | | | | | | | | | | | | | |
December 31, 2022 |
(In thousands) | Gross carrying amount | | Accumulated amortization | | Net carrying value |
Developed technology | $ | 1,302,101 | | | $ | 313,876 | | | |